Global Pets External Dewormer Market Size By Type (Injection, Unguent), By Application (Dogs, Cats), By Region, And Segment Forecasts, 2023 to 2032

The Global Pets External Dewormer Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.3 billion by 2031, expanding at a CAGR of 8.4% during the forecast period of 2023–2031. The market is gaining momentum due to increased pet adoption worldwide, growing awareness of pet health and hygiene, and a surge in the demand for preventive veterinary care. External dewormers play a crucial role in eliminating parasites such as fleas, ticks, and mites, which are commonly found in pets, especially dogs and cats.

The emphasis on companion animal well-being and the increased focus on regular deworming treatments, particularly in developed markets, are driving product innovation and the launch of combination therapies that treat multiple parasites. Moreover, e-commerce platforms are playing a pivotal role in making these products accessible to a larger customer base.

Drivers:

1. Rising Pet Ownership and Humanization of Pets:

The increasing trend of pet ownership, particularly in urban regions, is boosting the demand for external dewormers. As pets are increasingly viewed as family members, owners are more likely to invest in high-quality veterinary care products.

2. Growing Awareness of Zoonotic Diseases:

External parasites not only affect pets but can also pose risks to humans. This has led to increased awareness about regular deworming to prevent disease transmission, further supporting market growth.

3. Advancements in Veterinary Healthcare:

Innovations such as spot-on treatments, chewable tablets, and collars that provide prolonged protection are enhancing product efficacy and ease of use, driving customer adoption.

Restraints:

1. Adverse Reactions and Product Sensitivity:

Some pets may exhibit allergic or adverse reactions to certain chemical-based dewormers, discouraging pet owners from consistent use or leading them to seek alternatives.

2. Lack of Awareness in Emerging Economies:

Despite the growing pet population in developing regions, limited awareness about external parasites and preventive care is hindering market penetration.

Opportunity:

1. Expansion of E-commerce and Veterinary Telehealth:

Digital platforms are significantly widening product accessibility and promoting regular deworming routines via subscription models and teleconsultation reminders.

2. Rising Demand for Organic and Herbal Dewormers:

There is growing interest in plant-based dewormers with minimal side effects, offering a major growth opportunity for market players catering to the organic pet care segment.

Market by System Type Insights:

By system type, Spot-on Treatments dominated the market in 2023, accounting for the largest revenue share. Their ease of application, quick action, and long-lasting protection make them a preferred choice among pet owners. Oral Chewables, however, are gaining rapid popularity, especially for pets averse to topical treatments, and are expected to witness the fastest growth over the forecast period.

Market by End-use Insights:

Veterinary Clinics emerged as the leading end-use segment in 2023, driven by growing visits for preventive care and vaccinations. However, the Home Use segment, supported by rising e-commerce penetration and increased consumer education, is expected to register significant growth as DIY pet healthcare becomes more common.

Market by Regional Insights:

North America held the largest market share in 2023, driven by high pet ownership rates, robust veterinary infrastructure, and greater awareness of parasite-related health risks. Asia-Pacific is projected to be the fastest-growing region, thanks to rising pet adoption, increasing disposable income, and improved access to pet care products in countries like China, India, and Japan.

Competitive Scenario:

Key players in the Global Pets External Dewormer Market include Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Inc., Bayer AG (now part of Elanco), Virbac, Vetoquinol SA, Merck & Co., Inc., and Ceva Santé Animale. These companies are investing in product development, strategic partnerships, and expanding their distribution channels.

Key Market Developments:

In 2023, Zoetis launched a new chewable flea and tick treatment for dogs with extended 12-week protection.

In 2024, Elanco announced a partnership with online pet pharmacies to increase reach in remote markets.

In 2025, Virbac introduced a herbal-based external dewormer targeting the growing demand for organic pet care solutions.

Scope of Work – Global Pets External Dewormer Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.3 billion

CAGR (2023–2031) 8.4%

Market Segments By System Type (Spot-on, Oral, Collars), By End-use (Veterinary Clinics, Home Use), By Region

Growth Drivers Rising pet ownership, awareness of zoonotic diseases, advances in veterinary healthcare

Opportunities Expansion via e-commerce, demand for natural dewormers

FAQs:

1. What is the current market size of the Global Pets External Dewormer Market?

The market was valued at USD 1.2 billion in 2023.

2. What is the major growth driver of the Global Pets External Dewormer Market?

The market is driven by increasing pet ownership and awareness of preventive healthcare.

3. Which is the largest region during the forecast period in the Global Pets External Dewormer Market?

North America accounted for the largest market share in 2023.

4. Which segment accounted for the largest market share in Global Pets External Dewormer Market?

The Spot-on Treatment segment led the market by system type in 2023.

5. Who are the key market players in the Global Pets External Dewormer Market?

Key players include Zoetis, Elanco, Boehringer Ingelheim, Virbac, and Merck Animal Health.

Let me know if you'd like the report styled into a downloadable format or need another topic covered!